FINWIRES · TerminalLIVE
FINWIRES

研究快讯:永明金融公布第一季度运营每股收益小幅增长。

By

-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下: 永明金融公布2026财年第一季度基本每股收益为1.89美元,同比增长4%,与市场预期一致,但低于我们此前预测的1.93美元。报告业绩受到3.1亿美元一次性费用的显著影响,其中包括1.65亿美元的SLC Management收购费用和1.45亿美元的法律和解费用。亚洲市场表现突出,基本净利润同比增长17%至2.16亿美元,主要得益于香港强劲的销售势头和个人保险销售额41%的增长,巩固了其作为关键增长引擎的地位。加拿大市场基本净利润同比增长7%至3.7亿美元,主要得益于资产管理规模增长带来的手续费收入增加。资产管理业务业绩喜忧参半。由于追缴费用减少抵消了稳健的移动金融服务(MFS)业绩,基础净收入同比下降7%至3.63亿美元;同时,净流出资金从62亿美元扩大至178亿美元。我们认为,基础净资产收益率从17.7%提升至18.6%令人鼓舞,这反映出尽管面临运营逆风,但资本配置依然有效。

Related Articles

Asia

StarHub's Net Attributable Profit Falls 81% in Q1

StarHub's (SGX:CC3) net attributable profit to shareholders plunged 81% in the first quarter of the year to SG$5.9 million from SG$31.8 million a year earlier, according to a Thursday filing with the Singapore Exchange.Revenue declined 6.1% year over year to SG$507.3 million from SG$540.5 million, mainly due to an across-the-board decline in services revenue.

$SGX:CC3
Asia

Meesho Narrows Consolidated Loss in Fiscal Q4

Meesho (NSE:MEESHO, BOM:544632) narrowed its consolidated attributable loss to 1.66 billion Indian rupees in the fiscal fourth quarter ended March 31, from a loss of 13.9 billion rupees a year ago.Loss per share contracted to 0.36 rupees from a loss per share of 3.39 rupees a year earlier, the online marketplace said in a filing to the Indian stock exchanges on Wednesday. The loss per share was lower than the 0.73 rupees estimated by the analysts polled by Visible Alpha.Revenue from operations in fiscal Q4 increased to 35.3 billion rupees from 24.0 billion rupees a year ago. This is a tad higher than Visible Alpha's estimate of 35.2 billion rupees a year ago.

$BOM:544632$NSE:MEESHO
Asia

Changchun High-Tech Gets Regulatory Nod for Gouty Arthritis Drug

Changchun High-Tech Industry (SHE:000661) subsidiary Changchun Genescience Pharmaceutical obtained China's regulatory approval to manufacture and market its fuxinqibai monoclonal antibody injection.The drug is indicated for acute gouty arthritis attacks in adults poorly responsive to standard therapies, according to a Thursday filing with the Shenzhen bourse.

$SHE:000661
研究快讯:永明金融公布第一季度运营每股收益小幅增长。 | FINWIRES